Skip to main content

Table 1 Patient demographics

From: Effect of intraoperative blood transfusion on Treg and FOXP3 in patients with digestive tract malignancies and different ABO blood types

 

A

B

O

AB

F/χ2

P

Number of patients

20

20

20

20

  

Age (yr)

53.45 ± 5.29

53.55 ± 5.9

54 ± 5.52

54.95 ± 6.68

0.272

0.845

Sex (n)

    

0.158

0.984

 Male

8

8

7

8

  

 Female

12

12

13

12

  

BMI (kg/m2)

21.48 ± 1.98

22.47 ± 1.38

21.79 ± 1.78

21.8 ± 1.7

1.178

0.324

Tumor type (n)

    

5.348

0.803

 Rectal cancer

3

2

3

3

  

 Colon cancer

8

6

9

11

  

 Gastric cancer

8

11

8

6

  

 Esophageal cancer

1

1

0

0

  

Treatment history (n)

    

0.213

0.975

 No

8

7

7

8

  

 Chemoradiation

12

13

13

12

  

Preoperative hemoglobin (g/L)

83.95 ± 8.42

84.45 ± 10.2

83.25 ± 8.74

83.55 ± 7.88

0.690

0.976

Operative time (min)

200 ± 30.96

213.7 ± 40.98

218.95 ± 25.9

226.55 ± 29.57

2.394

0.075

Operative technique (n)

    

0.595

0.898

 Laparotomy

8

6

8

7

  

 Peritoneoscopy

12

14

12

13

  

Blood transfusion volume (ml)

 RBC

425.0 ± 99.9

456.0 ± 113.1

440.0 ± 96.9

450.5 ± 113.3

0.331

0.803

 Plasma

474.5 ± 154.5

442.0 ± 140.1

506.0 ± 167.4

514.0 ± 165.9

0.872

0.460

  1. Data are expressed as number or mean ± standard deviation. A blood group A, B blood group B, AB blood group AB, O blood group O, BMI Body–mass index, RBC red blood cells, T0 before surgery, T1 immediately after transfusion, T2 1 day after transfusion, T3 5 days after transfusion